Analyst consensus rating
Praxis Precision Medicines Analyst Rating: Strong Buy
Direct answer
Praxis Precision Medicines's consensus rating is Strong Buy.
21 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $650.00.
Forecast evidence checked October 19, 2026.
Get free Praxis Precision Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $241.76
- Average price target
- $650.00
- High price target
- $1,201.00
- Low price target
- $188.00
- Low target gap
- -22.2%
- Target upside
- +168.9%
- High target gap
- +396.8%
- Target range width
- 419%
- Consensus rating
- Strong Buy
- Analysts
- 21
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Praxis Precision Medicines?
Praxis Precision Medicines has a verified Strong Buy consensus. The same dataset has an average price target of $650.00.
How far are Praxis Precision Medicines's low and high targets from the recorded price?
The low target implies -22.2%, while the high target implies +396.8%.
How many analysts are included in Praxis Precision Medicines's consensus?
The verified consensus includes 21 analysts.
How is Praxis Precision Medicines's target upside or downside calculated?
The average target of $650.00 is divided by the recorded price of $241.76, then one is subtracted to produce +168.9%. This does not guarantee a future return.
When was Praxis Precision Medicines's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.